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Cancer Survivorship Clinics and the Financial Burden of Cancer on Patients 
Daniel Meehan, MHA 





 With rising costs associated with cancer care, a multidisciplinary cancer survivorship clinic 
approach becomes increasingly more important for optimal patient care. This essay aims to 
evaluate cancer survivorship clinic’s effectiveness with patient satisfaction and outcomes while 
also addressing factors contributing to cancer patient’s financial toxicity. Financial toxicity is used 
to describe the devastating consequences financially on the patient from rising cancer costs. This 
essay evaluates recent cancer survivorship research regarding effectiveness, satisfaction, and 
outcomes. Also, this essay evaluates cancer financial toxicity research regarding prevalence, risk 
factors, and the U.S. healthcare system impact. Cancer patients face much more than their cancer 
diagnosis. Cancer patients are faced with financial, psychosocial, and logistical challenges while 
battling cancer. Patient satisfaction and outcomes are greatly improved when treated in a 
multidisciplinary cancer clinic. Financial toxicity is a devastating consequence of cancer that many 
patients face. Factors such as increasing drug prices, loss of employment and limited health 
insurance benefits, and baseline economic status contribute to patient’s battle with financial 
toxicity. Financial toxicity can be managed better when a patient is treated in a multidisciplinary 
cancer clinic due to a more patient-centered approach. Implementation of cancer survivorship 
clinics can positively impact both patients and providers. Patients can receive their cancer care in 
 
 v 
one setting while improving their quality of life through decreased costs and fewer appointments. 
Providers are positively impacted by more effectively managing and addressing all aspects of a 
cancer patients’ diagnosis. In public health, this is significant because cancer survivorship clinics 
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 Cancer can be devastating to those impacted and the ramifications from cancer treatment 
can be equally as bad. Cancer is extremely prevalent, as seen by the 2020 National Cancer Institute 
report, “An estimated 1,806,590 new cases of cancer will be diagnosed in the United States and 
606,520 people will die from the disease” (“Cancer Statistics”, 2020). While a significant number 
of people will develop cancer, many will become cancer survivors after undergoing treatment. 
According to the National Cancer Institute, “As of January 2019, there were an estimated 16.9 
million cancer survivors in the United States. The number of cancer survivors is projected to 
increase to 22.3 million by 2030” (“Cancer Statistics”, 2020). Surviving cancer is an impressive 
feat, but post-cancer care can become burdensome financially, psychologically, and socially. 
Those battling cancer may not consider what their life will look like after they struggle with cancer. 
 Financial toxicity describes how patients struggle with finances due to all the out-of-pocket 
costs associated with treatment. With cancer being one of the most expensive medical conditions 
to treat in the United States of America, some of these expenses fall onto the patient after hitting 
their insurance maximums. Cancer survivors struggle financially with some survivors spending 
more than 20% of their annual income on medical care (“Financial toxicity (financial distress) and 
cancer treatment (pdq®)–patient version”, 2019). Various models of cancer care are seen 
throughout the US, but some are more suitable for combatting the consequences of financial 
toxicity among cancer survivors. Rising costs, additional stress, and decreased quality of life 
negatively contribute to a cancer patient’s journey.    
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2.0 Literature Review 
 
 
 Governmental agencies, Wiley Online Library, and cancer-focused research were the 
primary sources of information for the following text. The keywords used for many online searches 
were “Financial Toxicity” OR “Multidisciplinary Cancer Clinic” OR “Cancer Survivorship”. A 
review of peer-reviewed papers in the Medline database was analyzed to examine a 
multidisciplinary team approach. After an initial review, many studies and webpages were 

















 3.0 Overview of Cancer Survivorship and Clinics 
 
 
 Cancer survivorship is defined as, “An individual is considered a cancer survivor from the 
time of diagnosis, through the balance of his or her life. Family members, friends, and caregivers 
are also impacted by the survivorship experience and are therefore included in this definition” 
(“Survivorship Care”). While a patient endures cancer, so do their family, friends, and caregivers. 
The goals of cancer treatment are to “cure” cancer, if possible; prolong survival; and provide the 
best possible quality of life during and after treatment (“Cancer Treatment & Survivorship Facts 
& Figures 2019-2021”). There are a variety of cancer survivorship care programs across the U.S., 
but all have the common mission of providing high-quality treatment to cancer survivors. One 
approach is a multidisciplinary cancer survivorship clinic in which patients are seen during one 
visit by a multitude of health specialists. Navigating cancer care can be complex, but with the 
proper infrastructure and approach, patients can live a higher quality of life.   
 
3.1 Challenges with Improving the Quality of Survivorship Care 
 
 Many potential challenges are faced by cancer survivors. Survivorship care encompasses 
a range of issues faced by survivors including physical, mental, and social components of the 
cancer experience (Gilbert et al., 2008). With the aging of the population, an increase in the number 
of individuals diagnosed with cancer is an inevitable consequence. Maintaining high-quality care 
for cancer patients becomes even more difficult with the anticipated shortage of health 
professionals. A report from the Association of American Medical Colleges indicates, “The United 
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States will face a shortage of between 54,100 and 139,000 physicians by 2033” (Boyle, 2020). 
Specifically concerning the oncology field, “A fifth of oncologists are nearing retirement age of 
64 years or older and 15.6% of oncologists are early in their career at age 40 or below” (Cohn-
Emery, 2020). The combination of an aging population and improvements in cancer survival rates 
puts a strain on the oncology workforce in the future. Cancer therapies and management strategies 
have greatly improved, which has resulted in significant advancements in survival for cancer 
patients over the years. Still, despite improved therapies and management strategies, cancer 
patients will sometimes struggle to receive high-quality care due to the increase in individuals with 
cancer and the decrease in the oncology workforce.  
 Another challenge facing the quality of survivorship care is the coordination of care 
between health care professionals. Patients with cancer often require the expertise of many 
different health professionals. Two challenges are presented when a patient needs to be seen by a 
multitude of specialists. The patient needs to have the flexibility, time, and money to be seen by 
the various health professionals.  From the providers’ perspective, coordination amongst a group 
of health professionals is needed to maintain high-quality care throughout the survivorship care. 
Luckily, multidisciplinary cancer survivorship clinics allow a patient to be seen by a multitude of 
health care professionals during one visit. Multidisciplinary clinics (MDC) and multidisciplinary-
specific clinics differ in many ways. Two ways they are different are related to volume and 
expertise. MDCs for all cancer types have providers with vast knowledge and see large volumes 
of patients. Disease-specific MDCs lack the volume, but providers have expertise on that specific 
cancer.   
 While a patient’s cancer is being treated, there is growing evidence that the psychosocial 
needs of the patient are unmet (Ganz, 2009). The failure of treating a patient’s psychosocial needs 
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can compromise the intended results of cancer care. A combination of social isolation, stress, and 
untreated mental health problems can contribute to cancer patients’ interference with adhering to 
their treatment process. Depression, mental health problems, and limited financial resources 
contribute to the increased mortality and decreased functional status of the cancer patient (Adler, 
2008). Inadequate social support can negatively impact a cancer survivor’s experience. Inadequate 
income increases one’s stress and can make everyday life more complicated when purchasing 
necessities such as food, medications, shelter, and transportation. For example, a cancer patients’ 
inadequate income can complicate how they will travel to medical appointments or travel to the 
pharmacy for their prescriptions. With low income, transportation to these necessary medical 
appointments and medications becomes difficult. Fulfilling the psychosocial needs of cancer 
patients is a critical component for successful treatment and outcomes for those with cancer.  
 
3.2 Patient and Provider Satisfaction with Multidisciplinary Cancer Clinics 
 
 MDCs have become increasingly more prominent in the way cancer care is delivered to 
patients. MDCs focus on patient-centered care while allowing a patient to be seen by multiple 
healthcare professionals in a single visit. This integrated team approach results in improved health 
outcomes for patients. As defined in integrated MDC research, “A multidisciplinary (or 
multimodality) clinic is defined as a group of health care professionals who have cognitive and 
procedural expertise in different areas of care delivery and can efficiently manage complex 
medical conditions” (Tyler et al., 2015). This approach to patient care enables collaboration 
amongst healthcare professionals to consider the best treatment options and develop an 
individualized approach. Navigating cancer care can be difficult, but with the implementation of 
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multidisciplinary clinics, patients and physicians are typically more satisfied. In a research study 
analyzing patient satisfaction from the implementation of a multidisciplinary cancer clinic by 
Intermountain Healthcare, it was found, “98% of our patients gave us an excellent rating on the 
overall clinic experience” (Litton et al., 2010). The overall high satisfaction of the 
multidisciplinary cancer clinic is a result of patients receiving convenient high-quality care that 
results in excellent outcomes. Also, the clinic proved to be a vital source of expertise in one 
location for the patient. 
 To examine patient satisfaction with MDCs, a study was conducted looking at Press-Ganey 
patient satisfaction scores. Specifically, examining patients’ responses regarding the degree to 
which care between doctors and other health professionals was coordinated, the overall care is 
given at the facility, and the likelihood of recommending the services to others. The answers to the 
questions were reported on a scale from one to five. One being very poor and five being very good. 
Also, providers were asked about their perspectives on the advantages and drawbacks of MDCs. 
Specifically, providers were asked, “About the efficiency of the clinics, the clinics’ value for 
patients, providers’ personal preferences for working in these clinics, perceptions of patient 
satisfaction and, in an open-ended manner, any other comments or suggestions for improving the 
MDCs” (“Article tools”, 2016). The results from the provider’s responses showed that more than 
90% of providers enjoyed working in MDCs. 90% of providers perceived patients as appreciating 
the unique care provided in MDCs. Half of the providers thought the clinics did not run efficiently. 
Specifically, surgeons believed that MDCs were not an efficient use of their time. Surgeons did, 
however, believe the MDCs allowed them to deliver more comprehensive, coordinated, and 
appropriate care and agreed that patients appreciated the care they received due to the coordinated 
care approach (“Article tools”, 2016).  
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 The results from the Press-Ganey patient satisfaction scores showed consistent and high 
levels of satisfaction for MDCs. The four patient-related questions analyzed were, “The degree to 
which the staff worked together to provide care, the level of care coordination among doctors, the 
overall care received at the facility, and the more global assessment of the likelihood that patients 
would recommend services” (“Article tools”, 2016). The patient satisfaction percentage for each 
question was above 93% showing high levels of satisfaction regarding MDCs. High levels of 
patient satisfaction come at the cost of sometimes inefficient clinics. MDCs provide patients with 
a coordinated assessment and treatment plan for their complex oncologic disease. Providers have 
recognized the value that MDCs provide to patients. Overall, patients are highly satisfied with 
MDCs while providers are as well but some of the benefits come at a cost of less efficient 
operations.            
 
3.3 Patient Outcomes Associated with Multidisciplinary Cancer Clinics 
 
 Optimal patient care is increasingly associated with multidisciplinary teams (MDT). These 
MDTs include, “Core and allied members including radiologists, pathologists, surgeons, radiation 
and medical oncologists, oncology nurses, palliative care physicians, head and neck specialists, 
nuclear medicine specialist, respiratory disease physicians, gastrointestinal disease physicians and 
anesthesiologists” (Prades et al., 2015). In a study aiming to understand the impact of MDTs had 
on patient outcomes, fifty-one papers were selected for review on improved outcomes associated 
with multidisciplinary patient management. Of the fifty-one papers selected, two underlying 
principles were discovered as to why an MDT approach was best for patients. First, MDTs allowed 
more appropriate treatment with a preoperative review of imaging and pathology results (Prades 
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et al., 2015). Secondly, the MDT approach allowed the most up-to-date treatment for cancer 
patients. The review of peer-reviewed articles that examined multidisciplinary clinical practice and 
organization in cancer care showed, “MDTs resulted in better clinical and process outcomes for 
cancer patients, with evidence of improved survival among colorectal, head and neck, breast, 
oesophageal and lung cancer patients across the study period (2005-2012) (Prades et al., 2015). 
These results can be attributed to a reduced time from diagnosis to treatment, MDT organization, 
and communication with and delivery of information to patients. The collaboration amongst the 
multidisciplinary team evolved into a more comprehensive management approach from diagnosis 
to treatment and follow-up.  
 Head and neck cancer patients are best treated and managed using an MDT due to the 
complexity and diversified group of malignancies. In a study analyzing the differences in outcome 
and survival data of head and neck cancer patients between MDC managed care and non-MDC 
managed care, MDC managed care patients had significantly improved 5-year survival compared 
with the non-MDC managed patients (Friedland et al., 2011). MDC managed care was defined as 
patients working with various health specialists for an individualized treatment plan. Non-MDC 
managed patients were defined as those treated by individual disciplines in the same institution. 
When analyzing differences between MDCs versus non-MDCs, “Patients seen in the 
multidisciplinary clinic were significantly less likely to receive radiotherapy alone for positive 
nodes, significantly less likely to receive surgical treatment alone for their cancer and positive 
nodes” (Friedland et al., 2011). These differences can contribute to the difference in improved 





4.0 Financial Toxicity Among Cancer Survivors 
 
 
 Financial toxicity stems from cancer being one of the most expensive medical conditions 
to treat in the United States. Financial toxicity is used to describe, “How out-of-pocket costs can 
cause financial problems for a patient” (“Financial toxicity (financial distress) and cancer 
treatment (pdq®)–patient version”, 2019). Cancer patient’s out-of-pocket costs include 
copayments, deductibles, and coinsurance. In addition to the direct costs associated with treating 
cancer, indirect costs such as affecting one’s ability to work further contribute to financial 
hardship. Many factors contribute to the level of financial toxicity a cancer patient faces. Factors 
such as type of cancer, how severe it is, and how long one will receive treatment contributing to 
the level of financial toxicity a patient faces. Other contributing factors are one’s age, race, income, 
and the ability to have a job while undergoing cancer treatment and post-cancer. The type of 
insurance or absence of insurance affects the out-of-pocket costs a cancer patient is faced with. 
Overall, cancer survivors are more likely to report higher out-of-pocket spending than those that 
have not had cancer. In extreme examples, cancer survivors need to file for bankruptcy as indicated 
by cancer survivors being 2.7 times more likely to file for bankruptcy than individuals without 
cancer (“Financial toxicity (financial distress) and cancer treatment (pdq®)–patient version”, 
2019). In addition to navigating the complexities that come with a cancer diagnosis, patients must 
battle significant financial hardship.   
 A systematic review of financial toxicity among cancer patients revealed that being female, 
being younger in age, having lower income at baseline, using adjuvant therapies, and having a 
more recent diagnosis increase one’s risk of financial toxicity (Gordon et al., 2016). Cancer drugs 
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significantly contribute to the financial burden patients suffer from. Despite cancer drugs being 
the key to survival, the price for these drugs far exceeds the amount patients have to spend. 
According to the US Food and Drug Administration-Approved Oral Cancer Drugs from 2016 to 
2017 the cost per month of treatment can range from about $7500 to $25,000 monthly. With this 
steep price for drugs, many patients, despite being insured, reach their out-of-pocket maximum 
quickly. There is no sign of drug prices decreasing as indicated by a 10% increase in price or about 
$8,500, per year, between 1995 to 2013 – adjusted for inflation.    
 Clinicians play a unique role in managing financial toxicity among cancer patients. 
Clinicians have expressed concern regarding the affordability of cancer drugs, “Encouraging the 
development and use of generics and biosimilars, transparency in drug costs, negotiation of drug 
prices by Medicare, as well as high-value drug development” (Carrera et al., 2018). Clinicians 
have been supporters for more affordable treatments for those suffering from cancer. Clinicians 
play a key role in not just delivering high-quality medical treatments but helping patients navigate 
financial difficulty short-term and long-term. The clinician is many times the link between health 
insurance and the cancer clinic and advocates on behalf of their patients. Additionally, clinicians 
can use their position and promote high-quality cancer care which involves the avoidance of low-
value treatments. Clinicians are important in decreasing treatment costs and advocating on behalf 
of their patients.   
 
4.1 Factors Contributing to Financial Toxicity 
 
 The direct costs of cancer treatments are not the only factors contributing to financial 
toxicity among cancer patients. A study of those participating in the medical expenditure panel 
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survey found, “Patients undergoing cancer treatment missed 22.3 more days of work per year than 
people without cancer treatment” (“Financial toxicity after a cancer diagnosis - it's impact & 
factors - triage cancer-finances-work-insurance: Triage cancer”, 2021). Of the 89,520 patients who 
participated, low-income women were disproportionality affected. Beyond job loss, many cancer 
patients used their savings to pay for medical treatments – which contributes to considerable 
medical debt for some. The stress and financial concern of cancer patients and their families further 
contribute to financial toxicity. The physical, psychological and financial impact of cancer does 
not end when the treatment does. Those who are post-diagnosis still report increased financial 
stress along with depression and anxiety.  
 Loss of employment for cancer patients further complicates costs as a loss of employment 
limits access to employer health benefits. To eliminate this problem, a recent study found that 20% 
of cancer survivors stay in their jobs mainly to keep their health insurance (Pietrangelo, 2020). 
Continuing to work while in active treatment is sometimes a challenge. From finding the time for 
medically necessary appointments and treatment to fulfilling other obligations, patients that are 
employed endure additional stress along with battling cancer. Also, employers spend significantly 
more for those employees who have a cancer diagnosis compared to no diagnosis. In a study 
analyzing costs employers face it was reported, “For the period 2002-2005, the combined total 
annual cost for working patients undergoing chemotherapy was approximately $76,000 compared 
with approximately $21,000 for patients not receiving chemotherapy” (Lawless, 2009). This 
statistic indicates the long-term issues employers face, similar to the long-term effects cancer 




 The greatest risk of being affected by financial toxicity, unsurprisingly, are low-income 
patients and uninsured patients. Along with low-income and no insurance, African Americans and 
patients requiring more intense treatments have a higher risk of financial hardship. Not only does 
low-income contribute to a greater chance of suffering from financial toxicity, low- and middle-
income cancer patients suffer from higher cancer death rates. In a study examining death rates 
between incomes it was found, “ In low-income counties, the average cancer death rate in 2014 
was 230 per 100,000 people, compared with 205 per 100,000 in middle-income counties and 186 
per 100,000 in high-income counties” (“Factors linking disparities in cancer deaths, income”). 
Uninsured patients are at an increased risk of financial toxicity due to high costs not covered by a 
health insurer. Researchers found that before 2014, 5.7 percent of first-time cancer-diagnosed 
patients were uninsured. However, with the implementation of the Affordable Care Act, the 
percentage of first-time cancer-diagnosed patients decreased to 1.9 percent in 2014. (“ACA 
brought decline in new cancer patients who were uninsured, 2017”). African Americans are 
disproportionately affected by financial hardship related to cancer care. In a research study focused 
on the economic hardship of cancer survivors one year after diagnosis, approximately 68% of 
African Americans reported economic hardship. (Pisu et al., 2015). The disparity between white 
and African American economic hardship from cancer was explained by baseline economic status.  
 
4.2 How the US Healthcare System Impacts Cost 
 
 Patients receive cancer care in the U.S. through a continuum of coordinated care. Risk 
assessment and prevention is typically the first step in the continuum of care for cancer patients, 
followed by screening and detection, diagnosis, treatment, survivorship, and end-of-life care. 
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Several factors affect access to care including societal, health care system, provider issues, and 
patient factors (Yabroff et al., 2019). Multiple breakdowns in the delivery of health care through 
the cancer care continuum contribute to additional testing and cost. For example, a patient’s lack 
of follow-up on abnormal findings between the screening and detection and diagnosis stages can 
lead to serious consequences in the future.  
 Cancer care becomes challenging in the U.S. when coordination is needed across multiple 
insurance plans, hospitals, and practices – especially if medical records and patient data cannot be 
easily integrated. If medical records and patient data are not easily transferrable between facilities 
or providers, increased costs can occur indicated by, “ Despite ongoing efforts to improve health 
information technology infrastructure, this lack of coordination can result in duplication of 
services, overuse of ineffective care, underuse of effective care, and misuse of heath care services” 
(Yabroff et al., 2019). These inefficiencies contribute to the rising costs associated with cancer 
care. In addition to cost, these inefficiencies may contribute to health disparities among 
populations.     
 Disparities in care and cost in the U.S. can be contributed to the geographic location in 
which a patient resides. Patients that live in more rural locations lack the accessibilities to services 
or find them to be limited. The difference in mortality between rural areas and urban areas is 
growing wider due to a variety of factors including, “These patients may not be aware of the 
necessary screening modalities, are diagnosed at later stages, have overall worse outcomes, for 
many reasons have lesser interest for accrual1 on clinical trials, and experience negative 
psychological and financial impacts because of time spent traveling for treatment” (Petinga, 2019). 
The differences in mortality are complex but the underlying issues of how the U.S. healthcare 
system is structured is partially at fault. One factor is the number of oncologists serving urban and 
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rural communities, “More than 59 million Americans (19%) live in U.S. Census- designated rural 
areas, meaning that there is approximately one oncologist per 100,000 rural residents, compared 
with five oncologists per 100,000 urban residents” (Petinga, 2019). The sizable difference in the 
number of oncologists leads to a lack of access for those living in rural communities.     
       
4.3 How Multidisciplinary Clinics Mitigate Financial Toxicity 
 
 Head and neck cancer (HNC) patients need to see a wide range of specialists for optimal 
care. An HNC patient may need to be seen by an otolaryngologist, physical therapist, speech-
language pathologist, audiologist, behavioral health specialist, dentist, dietitian, and oncology 
nurse. Scheduling individual appointments to be seen by each specialist can be costly. The United 
States has enacted policies to shift away from the traditional fee-for-service model (Tom et al., 
2016). One such model is the bundled payment model, where a patient is charged a single payment 
for each appointment and the payment is shared among all providers who contributed to the 
appointment. This approach incentivizes the providers to deliver high-quality care and reduce 
administrative waste (Tom et al., 2016). Bundled payment model outcomes surrounding cancer 
care is limited, but they have generally shown decreased costs and positive outcomes. HNC costs 
are expensive and expected to only increase, “The cost of HNC in the United States was 
approximately $3.64 billion in 2012, and the projected cost in 2020 is between $3.79 billion and 
$5.46 billion” (Tom et al., 2016). A research study determining which factors influence cost in 
HNC to notify the development of a bundled payment concluded, “The number of treatment 
modalities required is the primary driver of cost in HNC” (Tom et al., 2016). This finding indicates 
bundled payments would help reduce costs amongst HNC patients. This research also indicated 
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that patient factors, including Charlson2 comorbidity index, had no significant impact on cost with 



























 When analyzing previous research regarding multidisciplinary cancer survivorship clinics, 
it is evident the benefits these settings have on patients. With the number of patients diagnosed 
with cancer on the rise along with costs to treat cancer increasing, implementing more cancer 
survivorship clinics is increasingly important. More data and research are needed to address how 
cancer survivorship clinics affect every type of cancer. While researching cancer clinics and 
financial toxicity, it was evident how important treating the psychosocial needs of the patient is. 
Treating the psychosocial needs of a cancer patient can positively influence the intended results of 
cancer treatment. It is difficult to understand exactly to what degree treating the psychosocial needs 
of a cancer patient has on cancer treatment. Each cancer patient is in a unique position concerning 
finances, support systems, and underlying mental health conditions. Further research is needed to 
understand how each unintended consequence of cancer negatively impacts cancer treatment.  
  The challenge of managing financial toxicity was prevalent throughout all research. The 
multidisciplinary approach provided some relief in costs due to providers collaborating more and 
providing more effective care to cancer patients. One payment is typically collected when a patient 
visits a multidisciplinary clinic. Further research is needed to determine how to ensure this bundled 
payment model can be sustained for the hospital. Patient satisfaction and outcomes are positively 
affected by multidisciplinary clinics, but how the hospital can remain profitable while only 
charging one fee for multiple providers needs further evaluation.   
 Patients living in more rural geographic locations face additional challenges that patients 
living closer to a city do not face. Patients in rural communities are disproportionately affected by 
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the oncologist shortage. Patients in rural communities may have more difficulty accessing 
necessary cancer treatments and therefore negatively suffer due to delayed diagnoses, lack of 
awareness for cancer screening, and spend significantly more time traveling to appointments. 
Further investigation is needed to determine how rural communities can become more aware of 
cancer diagnoses and properly be diagnosed. With earlier intervention, patients can better manage 























 Cancer patients need to receive high-quality care while going through a traumatic time in 
their life. Patients face much more than their cancer diagnosis as they struggle with financial, 
psychosocial, and logistical difficulties as well. Untreated mental health problems and inadequate 
social support can further compromise effective cancer treatment. Additional stress from life’s 
challenges can adversely affect patient treatment outcomes. Cancer patients face logistical 
difficulties with the number of appointments required for their care while maintaining a job and 
health insurance benefits. High-quality patient care can come from MDCs due to their unique 
approach and structure. From the healthcare provider’s perspective, a combination of better cancer 
drugs that allow patients to live longer and a decrease in the oncology workforce put a strain on 
providing optimal patient care. MDCs can alleviate patient and provider stress with the adoption 
of patient-center care while allowing providers to better care for their patients. Besides some 
inefficiencies seen by surgeons in how MDCs, both patients and providers are generally more 
satisfied with this approach to their cancer care.  MDCs ensure patient-centered care due to 
multiple specialists working together to deliver optimal results. Not only does the multidisciplinary 
approach improve patient satisfaction and outcomes, but cancer patient financial toxicity can also 
be managed better. Incorporating a multidisciplinary cancer clinic approach can save cancer 
patients every year between a bundled payment option and decrease the number of appointments. 
Also, indirect costs from cancer treatment can be avoided, such as not missing work or losing 
health insurance benefits due to not working, with MDCs. From a public health perspective, MDCs 
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allow patients to receive optimal care while reducing the additional stress a cancer diagnosis 
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